{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:48:20Z","timestamp":1789181300349,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007176","name":"Scuola Superiore Sant'Anna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007176","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cardiac amyloidosis (CA) may affect all cardiac structures, including the valves. From 423 patients undergoing a diagnostic workup for CA we selected 2 samples of 20 patients with amyloid transthyretin (ATTR-) or light-chain (AL-) CA, and age- and sex-matched controls. We chose 31 echocardiographic items related to the mitral, aortic and tricuspid valves, giving a value of 1 to each abnormal item. Patients with ATTR\u2013CA displayed more often a shortened\/hidden and restricted posterior mitral valve leaflet (PMVL), thickened mitral chordae tendineae and aortic stenosis than those with AL\u2013CA, and less frequent PMVL calcification than matched controls. Score values were 15.8 (13.6\u201317.4) in ATTR\u2013CA, 11.0 (9.3\u201314.9) in AL\u2013CA, 12.8 (11.1\u201314.4) in ATTR\u2013CA controls, and 11.0 (9.1\u201313.0) in AL\u2013CA controls (p\u2009=\u20090.004 for ATTR- vs. AL\u2013CA, 0.009 for ATTR\u2013CA vs. their controls, and 0.461 for AL\u2013CA vs. controls). Area under the curve values to diagnose ATTR\u2013CA were 0.782 in patients with ATTR\u2013CA or matched controls, and 0.773 in patients with LV hypertrophy. Patients with ATTR\u2013CA have a prominent impairment of mitral valve structure and function, and higher score values. The valve score may help identify patients with ATTR\u2013CA among patients with CA or unexplained hypertrophy.<\/jats:p>","DOI":"10.1007\/s10554-023-02901-2","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T01:03:31Z","timestamp":1687309411000},"page":"1873-1887","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Valve disease in cardiac amyloidosis: an echocardiographic score"],"prefix":"10.1007","volume":"39","author":[{"given":"Alberto","family":"Aimo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Fabiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnese","family":"Maccarana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Vergaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladyslav","family":"Chubuchny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio Maria","family":"Pasanisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Poggianti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Giannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Spini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Taddei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Castiglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Passino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Emdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Venneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,21]]},"reference":[{"key":"2901_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000444206","volume":"2","author":"HL Nienhuis","year":"2016","unstructured":"Nienhuis HL, Bijzet J, Hazenberg BP (2016) The prevalence and management of systemic amyloidosis in Western countries. Kidney Dis 2:10\u201319","journal-title":"Kidney Dis"},{"key":"2901_CR2","doi-asserted-by":"publisher","DOI":"10.1177\/2047487319877708","author":"G Vergaro","year":"2019","unstructured":"Vergaro G, Aimo A, Barison A et al (2019) Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings. Eur J Prev Cardiol. https:\/\/doi.org\/10.1177\/2047487319877708","journal-title":"Eur J Prev Cardiol"},{"key":"2901_CR3","doi-asserted-by":"publisher","DOI":"10.1177\/2047487319884371","author":"CS Kwok","year":"2019","unstructured":"Kwok CS, Farzaneh-Far A, Mamas MA (2019) Red flags in cardiac amyloidosis. Eur J Prev Cardiol. https:\/\/doi.org\/10.1177\/2047487319884371","journal-title":"Eur J Prev Cardiol"},{"key":"2901_CR4","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.jcmg.2019.10.011","volume":"13","author":"M Boldrini","year":"2020","unstructured":"Boldrini M, Cappelli F, Chacko L et al (2020) Multiparametric echocardiography scores for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 13:909\u2013920","journal-title":"JACC Cardiovasc Imaging"},{"key":"2901_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/circimaging.116.005066","author":"TA Treibel","year":"2016","unstructured":"Treibel TA, Fontana M, Gilbertson JA et al (2016) Occult transthyretin cardiac amyloid in severe calcific aortic stenosis: prevalence and prognosis in patients undergoing surgical aortic valve replacement. Circ Cardiovasc Imaging. https:\/\/doi.org\/10.1161\/circimaging.116.005066","journal-title":"Circ Cardiovasc Imaging"},{"key":"2901_CR6","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1002\/ejhf.1756","volume":"22","author":"C Nitsche","year":"2020","unstructured":"Nitsche C, Aschauer S, Kammerlander AA et al (2020) Light-chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome. Eur J Heart Fail 22:1852\u20131862","journal-title":"Eur J Heart Fail"},{"key":"2901_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jacc.2020.11.006","volume":"77","author":"C Nitsche","year":"2021","unstructured":"Nitsche C, Scully PR, Patel KP et al (2021) Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis. J Am Coll Cardiol 77:128\u2013139","journal-title":"J Am Coll Cardiol"},{"key":"2901_CR8","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","volume":"38","author":"A Casta\u00f1o","year":"2017","unstructured":"Casta\u00f1o A, Narotsky DL, Hamid N et al (2017) Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J 38:2879\u20132887","journal-title":"Eur Heart J"},{"key":"2901_CR9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jaccao.2021.08.008","volume":"3","author":"AK Singal","year":"2021","unstructured":"Singal AK, Bansal R, Singh A et al (2021) Concomitant transthyretin amyloidosis and severe aortic stenosis in elderly Indian population: a pilot study. JACC Cardio-oncol 3:565\u2013576","journal-title":"JACC Cardio-oncol"},{"key":"2901_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12947-019-0182-y","volume":"17","author":"G Pesk\u00f3","year":"2019","unstructured":"Pesk\u00f3 G, Jenei Z, Varga G et al (2019) Coexistence of aortic valve stenosis and cardiac amyloidosis: echocardiographic and clinical significance. Cardiovasc Ultrasound 17:32","journal-title":"Cardiovasc Ultrasound"},{"key":"2901_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s12254-021-00678-5","volume":"14","author":"C Binder","year":"2021","unstructured":"Binder C, Duca F (2021) Diagnosis and supportive therapeutic management of cardiac light chain amyloidosis\u2014a cardiologist\u2019s perspective. MEMO 14:89\u201397","journal-title":"MEMO"},{"key":"2901_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.0954-6820.1983.tb10634.x","volume":"214","author":"C Backman","year":"1983","unstructured":"Backman C, Olofsson BO (1983) Echocardiographic features in familial amyloidosis with polyneuropathy. Acta Med Scand 214:273\u2013278","journal-title":"Acta Med Scand"},{"key":"2901_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00392-016-1058-x","volume":"106","author":"DPS Mohty","year":"2017","unstructured":"Mohty DPS, Magne J, Fadel B, Petitalot V, Aboyans V, Jaccard A (2017) Prevalence and prognostic impact of left-sided valve thickening in systemic light-chain amyloidosis. Clin Res Cardiol 106:331\u2013340","journal-title":"Clin Res Cardiol"},{"key":"2901_CR14","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","volume":"133","author":"JD Gillmore","year":"2016","unstructured":"Gillmore JD, Maurer MS, Falk RH et al (2016) Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 133:2404\u20132412","journal-title":"Circulation"},{"key":"2901_CR15","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1177\/2047487319877708","volume":"27","author":"G Vergaro","year":"2020","unstructured":"Vergaro G, Aimo A, Barison A et al (2020) Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings. Eur J Prev Cardiol 27:1806\u20131815","journal-title":"Eur J Prev Cardiol"},{"key":"2901_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jcmg.2019.03.026","volume":"13","author":"A Baggiano","year":"2020","unstructured":"Baggiano A, Boldrini M, Martinez-Naharro A et al (2020) Noncontrast magnetic resonance for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 13:69\u201380","journal-title":"JACC Cardiovasc Imaging"},{"key":"2901_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1-39.e14","journal-title":"J Am Soc Echocardiogr"},{"key":"2901_CR18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","volume":"29","author":"SF Nagueh","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29:277\u2013314","journal-title":"J Am Soc Echocardiogr"},{"key":"2901_CR19","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","volume":"38","author":"H Baumgartner","year":"2017","unstructured":"Baumgartner H, Falk V, Bax JJ et al (2017) 2017 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 38:2739\u20132791","journal-title":"Eur Heart J"},{"key":"2901_CR20","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"LG Rudski","year":"2010","unstructured":"Rudski LG, Lai WW, Afilalo J et al (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a Report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23:685\u2013713","journal-title":"J Am Soc Echocardiogr"},{"key":"2901_CR21","doi-asserted-by":"publisher","first-page":"908","DOI":"10.4070\/kcj.2019.0200","volume":"49","author":"JH Park","year":"2019","unstructured":"Park JH (2019) Two-dimensional echocardiographic assessment of myocardial strain: important echocardiographic parameter readily useful in clinical field. Korean Circ J 49:908\u2013931","journal-title":"Korean Circ J"},{"key":"2901_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13449","volume":"51","author":"A Aimo","year":"2021","unstructured":"Aimo A, Chubuchny V, Vergaro G et al (2021) A simple echocardiographic score to rule out cardiac amyloidosis. Eur J Clin Investig 51:e13449","journal-title":"Eur J Clin Investig"},{"key":"2901_CR23","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/ehf2.12668","volume":"7","author":"VK Randhawa","year":"2020","unstructured":"Randhawa VK, Vakamudi S, Phelan DM et al (2020) Mitral and tricuspid stenosis caused by light chain cardiac amyloid deposition. ESC Heart Fail 7:1130\u20131135","journal-title":"ESC Heart Fail"},{"key":"2901_CR24","volume-title":"Catheter management of mitral stenosis","author":"KN Brown","year":"2021","unstructured":"Brown KN, Kanmanthareddy A (2021) Catheter management of mitral stenosis. StatPearls Publishing, Treasure Island"},{"key":"2901_CR25","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0344-0338(86)80150-9","volume":"181","author":"A Eriksson","year":"1986","unstructured":"Eriksson A, Olofsson BO, Eriksson P (1986) Heart valve involvement in familial amyloidosis with polyneuropathy. Pathol Res Pract 181:563\u2013567","journal-title":"Pathol Res Pract"},{"key":"2901_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00392-016-1058-x","volume":"106","author":"D Mohty","year":"2017","unstructured":"Mohty D, Pradel S, Magne J et al (2017) Prevalence and prognostic impact of left-sided valve thickening in systemic light-chain amyloidosis. Clin Res Cardiol 106:331\u2013340","journal-title":"Clin Res Cardiol"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-023-02901-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-023-02901-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-023-02901-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T02:17:55Z","timestamp":1697768275000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-023-02901-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,21]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["2901"],"URL":"https:\/\/doi.org\/10.1007\/s10554-023-02901-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2298478\/v1","asserted-by":"object"}]},"ISSN":["1875-8312"],"issn-type":[{"value":"1875-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,21]]},"assertion":[{"value":"21 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}